FORTE BIOSCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 837.00 shares.
- FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-12-31 was 0.00 shares.
- FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 2.84K shares.
- FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 1.10K shares, a 96.29% decline from fiscal 2021.
- FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 29.57K shares, a 60.48% decline from fiscal 2020.
- FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2020 was 74.84K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-31 | 837.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 2.84K shares 10-K · filed 2026-03-31 |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | 1.10K shares 10-K · filed 2023-03-31 |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | 1.10K shares derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | 21.08K shares derived: sum of 4 quarters · filed 2022-08-15 |
| 2022-03-31 | 1.10K shares 10-Q · filed 2022-05-16 | 23.02K shares derived: sum of 4 quarters · filed 2022-05-16 |
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | 29.57K shares 10-K · filed 2022-03-31 |
| 2021-09-30 | 19.98K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | 29.57K shares derived: sum of 4 quarters · filed 2021-11-08 |
| 2021-06-30 | 1.94K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | 27.84K shares derived: sum of 4 quarters · filed 2021-08-16 |
| 2021-03-31 | 7.66K shares 10-Q · filed 2021-05-10 | |
| 2020-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | 74.84K shares 10-K · filed 2021-03-16 |
| 2020-09-30 | 18.25K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 |